Overview

Downstream Bioprocessing Controllers Market is estimated to value over USD 2 billion by 2027 end with a CAGR of over 17% during the forecast period 2020 to 2027.

Rising insistence for biopharmaceuticals, increased acceptance of single-use technology, expansion of the capacity by the companies manufacturing biopharmaceutical products are some of the key factors driving the market growth. Furthermore, rising penetration of large molecules and biologics shall increase the acceptance of downstream methods, thereby proliferating the market. Purity, reasonable unit cost and efficacy are some of the key parameters to be considered for producing drugs. Downstream technique is often used in both industrial as well as lab applications due to an escalated insistence for biologics, which shall augment the downstream bioprocessing controllers market growth. 
High throughput in the development process, perfusion chromatography, usage of data analytics and affinity chromatography are some of the crucial developments in downstream processing. Furthermore, the advantages related to the single use technology like substantial reduction in the facility construction time and capital cost which shall accelerate the growth of the market. Other benefits like improves mobility, increased scalability, eliminating cross contamination risk, reduced demand for sterilization and cleaning and high productivity shall boost the demand for downstream method significantly. The key market players are initiating multiple research and development activities for cutting down the total production cost, thereby minimizing the cost of retail products. These activities have escalated the investments in biotech research, thereby shortening the time of processing and the scope of throughput. 

Market Segmentation:

By Procedure
•    Chromatography
•    Tangential Flow Filtration
By Product
•    Chromatography Controller System
•    TFF Controller System
•    Disposable Floe Path
By Application
•    Commercial Bioprocessing
•    Research Bioprocessing
By End User
•    Pharmaceutical and Biotechnology Companies
•    Academic and Research Institutes
•    Contract Research Organizations
•    Food and Beverage Companies     
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is classified into procedure, product, application, end user and region. The procedure segment is fragmented into chromatography and tangential flow filtration. The tangential flow filtration procedure is predicted to hold the largest downstream bioprocessing controllers market share owing to a rise in the acceptance of tangential flow filtration processes for removing biofilm, bioburden and reducing endotoxin from biopharmaceutical fluids and all this with no effect on the product quality. Product-wise, the market is divided into chromatography controller system, TFF controller system, disposable flow path. The TFF products like disposable flow path dominated the market and this can be credited to an increased acceptance of TFF processes implemented with single use technology in meeting the rising insistence for concentrated protein with reduced time and capital investment. The application segment is divided into commercial bioprocessing and research bioprocessing. The commercial bioprocessing segment is fragmented into monoclonal antibody production, therapeutic protein production, vaccine production and cell and gene therapy. The commercial bioprocessing is predicted to lead the market and this mainly due to increased insistence for biopharmaceutical products, rise in the number of approvals for antibody products. The end user segment is categorised into pharmaceutical and biotechnology companies, contract manufacturing organization and academic and research institutes. The pharmaceutical and biotechnology companies led the market, and this can be credited to a high rate of consumption of bioprocessing consumables and equipment by these companies. 

Regional Analysis:

The North America region is anticipated to dominate the market owing to the advancements in downstream technology and a strong presence of key biopharmaceutical companies in the region. Furthermore, the government has heavily invested in the research and development activities pertaining to bioprocessing controllers which has boosted the market growth in the region. The Asia Pacific region is expected to grow at a substantial rate during the forecast period with key players expanding their businesses in the region. For instance, JHL Biotech of Taiwan uses modular SUT that is provided by GE Healthcare Life Sciences for constructing a biopharma facility in the province of Wuhan, China. There has been a rise in the number of approvals of biologics in developing and developed countries like China, Japan. For example, Chugai Pharmaceutical Co. Ltd. from Japan and the National Cancer Center, Japan has signed a research agreement for the project Master Key which shall promote R&D in genomic medicines and cancer medicines. 

Competitive Landscape:                            

Some of the key players involved are Merck Group, Danaher Corporation, GE Healthcare, ARTeSYN Biosolutions Ireland Ltd, Sepragen Corporation, Parker-Hannifin Corporation, 3M Company, VERDOT Ips², Repligen Corporation, Sartorius AG. 

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global downstream bioprocessing controllers market by procedure, by product, by application, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

  1. Market Introduction
            1.1 Objectives of the Study 
            1.2 Market Definition 
            1.3 Market Scope 
                  1.3.1 Years Considered for the Study
                  1.3.2 Market Covered
            1.4 Currency
            1.5 Limitations 
            1.6 Stakeholders 
2. Research Methodology 
            2.1 Research Data 
                 2.1.1 Secondary Data
                         2.1.1.1 Key Data from Secondary Sources
                 2.1.2 Primary Data
                         2.1.2.1 Key Data from Primary Sources
            2.2 Market Size Estimation 
            2.3 Market Breakdown and Data Triangulation 
            2.4 Assumptions for the Study  
3. Executive Summary
            3.1 Market Outlook
            3.2 Segment Outlook
            3.3 Competitive Insights
4. Market Variables, Trends & Scope
            4.1 Market Lineage Outlook
            4.2 Penetration and Growth Prospect Mapping
            4.3 Industry Value Chain Analysis
            4.4 Cost Analysis Breakdown
            4.5 Technology Overview
            4.6 Regulatory Framework on Country Level
                 4.6.1 Reimbursement Framework    
                 4.6.2 Standards and Compliances
5. Market Overview
            5.1 Market Dynamics
                  5.1.1 Market Driver Analysis         
                  5.1.2 Market Restraint Analysis         
                  5.1.3 Industry Challenges                   
6. Market Analysis tools                      
            6.1 Industry Analysis - Porter’s
                     6.1.1 Supplier Power
                     6.1.2 Buyer Power
                     6.1.3 Substitution Threat
                     6.1.4 Threat from new entrants
                     6.1.5 Competitive Rivalry                  
            6.2 Pestel Analysis
                     6.2.1 Political Landscape
                     6.2.2 Environmental Landscape
                     6.2.3 Social landscape
                     6.2.4 Technology landscape
                     6.2.5 Legal Landscape
7. Downstream Bioprocessing Controllers Market, By Procedure Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
            7.1 Chromatography
            7.2 Tangential Flow Filtration                   
8. Downstream Bioprocessing Controllers Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
            8.1 Chromatography Controller System
            8.2 TFF Controller System
            8.3 Disposable Floe Path     
9. Downstream Bioprocessing Controllers Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
            9.1 Commercial Bioprocessing
                  9.1.1 Monoclonal Antibody Production
                  9.1.2 Therapeutic Protein Production
                  9.1.3 Vaccine Production
                  9.1.4 Cell and Gene Therapy
            9.2 Research Bioprocessing
10. Downstream Bioprocessing Controllers Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
            10.1 Pharmaceutical and Biotechnology Companies
            10.2 Academic and Research Institutes
            10.3 Contract Research Organizations
            10.4 Food and Beverage Companies         
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
            11.1. Introduction
            11.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                   11.2.1. U.S.
                   11.2.2. Canada
                   11.2.3. Mexico 
                   11.2.4. Rest of North America
            11.3 Market Size (USD Mn) Forecast for North America 2020-2027
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
            12.1. Introduction
            12.2. Regional Market Trends
            12.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                    12.3.1. Brazil
                    12.3.2. Venezuela
                    12.3.3. Argentina
                    12.3.4. Rest of Latin America
            12.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
            13.1. Introduction
            13.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                13.2.1. Germany
                13.2.2. U.K
                13.2.3. France
                13.2.4. Italy
                13.2.5 Switzerland
                13.2.6. Spain
                13.2.7. Russia
                13.2.8. Poland
                13.2.9. Rest of Western Europe
            13.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
            14.1 Introduction
            14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 14.2.1 Japan
                 14.2.2 China
                 14.2.3 Singapore
                 14.2.4 Korea         
                 14.2.5 India
                 14.2.6 Australia and New Zealand
                 14.2.7 ASEAN
                 14.2.8 Rest of Asia Pacific
            14.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
            15.1 UAE
            15.2 South Africa
            15.3 Egypt
            15.4 Saudi Arabia
            15.5 Rest of MEA
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    16.1 Merck Group
            16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.1.2. Product Portfolio
            16.1.3. SWOT Analysis
            16.1.4. Financial Overview
            16.1.5. Strategic Overview
    16.2 GE Healthcare
               16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
               16.2.2. Product Portfolio
               16.2.3. SWOT Analysis
               16.2.4. Financial Overview
               16.2.5. Strategic Overview
    16.3 ARTeSYN Biosolutions Ireland Ltd
              16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.3.2. Product Portfolio
              16.3.3. SWOT Analysis
              16.3.4. Financial Overview
              16.3.5. Strategic Overview
    16.4 Sepragen Corporation
             16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
             16.4.2. Product Portfolio
             16.4.3. SWOT Analysis
             16.4.4. Financial Overview
             16.4.5. Strategic Overview
    16.5 Parker-Hannifin Corporation
              16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
             16.5.2. Product Portfolio
              16.5.3. SWOT Analysis
              16.5.4. Financial Overview
              16.5.5. Strategic Overview
    16.6 3M Company
               16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
               16.6.2. Product Portfolio
               16.6.3. SWOT Analysis
               16.6.4. Financial Overview
               16.6.5. Strategic Overview
    16.7 VERDOT Ips²
               16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
               16.7.2. Product Portfolio
               16.7.3. SWOT Analysis
               16.7.4. Financial Overview
               16.7.5. Strategic Overview
    16.8 Repligen Corporation
              16.8.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.8.2. Product Portfolio
              16.8.3. SWOT Analysis
              16.8.4. Financial Overview
              16.8.5. Strategic Overview    
    16.9 Sartorius AG
              16.9.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.9.2. Product Portfolio
              16.9.3. SWOT Analysis
              16.9.4. Financial Overview
              16.9.5. Strategic Overview
17. Impact of COVID-19
      17.1. Positive influence on the healthcare industry
      17.2. The financial disruption of the manufacturing sector
      17.3. Impact of COVID-19 on emerging companies
      17.4. Significant mandates in the healthcare regulations initiated by administrations
      17.5. The overall economic slowdown of the developing and developed nations
18. Competitive Intelligence and Competitive Matrix
      18.1 Competitive Intelligence
      18.2 Competitive Matrix
19. Major Deals and Strategic Alliances Analysis
      19.1 Joint ventures
      19.2 Mergers and acquisitions              
      19.3 Licensing and partnerships
      19.4 Technology Collaborations
      19.5 Strategic Divestments
      19.6 Market Entry Strategies                         
20. Relevant Case Studies and Latest News Updates
21. Research Sources and List of Primary Contacts of this Study
22. Key Market Takeaway Points from the Market Analysts at Future Market Analytics 

Tables

Figures